- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 273/08 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups having two nitrogen atoms and more than one oxygen atom
Patent holdings for IPC class C07D 273/08
Total number of patents in this class: 57
10-year publication summary
1
|
2
|
2
|
11
|
2
|
3
|
0
|
5
|
1
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Teijin Limited | 1246 |
9 |
Aurigene Oncology Limited | 110 |
5 |
Massachusetts Institute of Technology | 10055 |
4 |
The Kitasato Institute | 151 |
3 |
Bayer Animal Health GmbH | 221 |
2 |
Korea Advanced Institute of Science and Technology | 4382 |
2 |
Aurigene Discovery Technologies Limited | 99 |
2 |
Institute for Basic Science | 351 |
2 |
Stratoxer(s) Kft. | 2 |
2 |
Sanofi | 4065 |
2 |
Amgen Inc. | 4044 |
1 |
FUJIFILM Corporation | 29399 |
1 |
Henkel AG & Co. KGaA | 10574 |
1 |
Purdue Research Foundation | 3615 |
1 |
Blade Therapeutics, Inc. | 19 |
1 |
Ecole Nationale Superieure de Chimie de Paris | 53 |
1 |
Erasmus University Medical Center Rotterdam | 338 |
1 |
The Governors of the University of Alberta | 867 |
1 |
Heinrich-heine-universitat Dusseldorf | 76 |
1 |
Janssen Biotech, Inc. | 1548 |
1 |
Other owners | 14 |